Research progression of translational medicine in gastric cancer.
- Author:
Maoran LI
1
;
Gang ZHAO
;
Chunchao ZHU
Author Information
1. Department of Gastrointestinal Surgery, Renji Hospital, School of Medical, Shanghai Jiaotong University, Shanghai 200127, China. zhaogang74313@aliyun.com.
- Publication Type:Journal Article
- MeSH:
Chemotherapy, Adjuvant;
Combined Modality Therapy;
Humans;
Prognosis;
Stomach Neoplasms;
drug therapy;
Translational Medical Research
- From:
Chinese Journal of Gastrointestinal Surgery
2014;17(2):192-195
- CountryChina
- Language:Chinese
-
Abstract:
Gastric cancer is one of the most common malignant tumors which is a great threat to human health. In recent years, the reform of surgical mordalities and the optimization of radiation and chemotherapy is still far from reducing morbidity and mortality of gastric cancer. As a new research pattern, translational medicine has emerged in various clinical subjects, which leads to remarkable effects. In this paper, the definition and development of translational medicine, molecular markers and drug treatment of gastric cancer will be discussed and the feasibility of translational medicine in the treatment of gastric cancer will be explained. In our opinion, the intervention of translational medicine could change the current situation that scientific researches is severely disconnected with clinical practice and increase the detection rate of gastric cancer and the effective rate of adjuvant therapy after surgery to improve the prognosis of patients with gastric cancer.
